Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) |
Cardiovascular Disease and Lipoprotein(a) | Phase3 | Argentina Australia Austria Belgium Brazil Bulgaria Canada China Colombia Czechia Denmark France Germany Greece Hong Kong Hungary India Israel Italy Japan Netherlands Poland Portugal Puerto Rico Romania Russia Slovakia South Korea Spain Switzerland Taiwan Turkey (Türkiye) United Kingdom United States View all |
NCT07517263 |
Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China |
HR+/HER2- Advanced or Metastatic Breast Cancer | China | NCT07476170 | |
Impact of Implementation Strategies on Lp(a) Testing in Secondary Care Settings |
Implementing EAS/ESC Guideline Recommendation on Lp(a) Testing in Routine Practice | Germany | NCT07508007 | |
Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China |
Chronic Myeloid Leukemia in Chronic Phase | China | NCT07375355 | |
A Study to Assess the Effects of Zigakibart on IgA Nephropathy. |
Immunoglobulin A Nephropathy (IgAN) | Phase2 | China Japan Poland South Korea Taiwan United States View all |
NCT07146906 |
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia |
Schizophrenia | Phase2 | United States | NCT07467993 |
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo |
Non-segmental Vitiligo | Phase2 | Australia Canada China Japan United States View all |
NCT07431177 |
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease |
Huntington Disease | Phase3 | Canada United Kingdom United States |
NCT07326709 |
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration |
Geographic Atrophy Secondary to Age-related Macular Degeneration | Phase2 | Australia Canada Hungary Poland United States View all |
NCT07441642 |
Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea |
Hidradenitis Suppurativa, Pediatric Plaque Psoriasis, Juvenile Idiopathic Arthritis | South Korea | NCT07243782 |